International Stem Cell Corporation
ISCO
$0.51
$0.024.49%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.32M | 2.16M | 2.37M | 2.45M | 2.13M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.32M | 2.16M | 2.37M | 2.45M | 2.13M |
| Cost of Revenue | 954.00K | 1.07M | 1.05M | 927.00K | 992.00K |
| Gross Profit | 1.36M | 1.09M | 1.32M | 1.52M | 1.14M |
| SG&A Expenses | 1.40M | 1.82M | 1.07M | 1.19M | 1.17M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.51M | 2.47M | 2.28M | 2.28M | 2.34M |
| Operating Income | -190.00K | -313.00K | 94.00K | 167.00K | -215.00K |
| Income Before Tax | -220.00K | -348.00K | 57.00K | 129.00K | -256.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -220.00K | -348.00K | 57.00K | 129.00K | -256.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -220.00K | -348.00K | 57.00K | 129.00K | -256.00K |
| EBIT | -190.00K | -313.00K | 94.00K | 167.00K | -215.00K |
| EBITDA | -156.00K | -259.00K | 150.00K | 221.00K | -160.00K |
| EPS Basic | -0.03 | -0.04 | 0.00 | 0.01 | -0.03 |
| Normalized Basic EPS | -0.02 | -0.03 | 0.00 | 0.01 | -0.02 |
| EPS Diluted | -0.03 | -0.04 | 0.00 | 0.01 | -0.03 |
| Normalized Diluted EPS | -0.02 | -0.03 | 0.00 | 0.01 | -0.02 |
| Average Basic Shares Outstanding | 8.00M | 8.00M | 8.00M | 8.00M | 8.00M |
| Average Diluted Shares Outstanding | 8.00M | 8.00M | 8.17M | 8.00M | 8.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |